The independent platform for news, articles and advice for professionals in laboratory medicine

NEWS

IBMS, RCPath and ACB collaborate for POCT guidance

IBMS, RCPath and ACB collaborate for POCT guidance

The Institute of Biomedical Science (IBMS) has collaborated with The Royal College of Pathologists (RCPath) and The Association for Clinical Biochemistry and Laboratory Medicine (ACB) to produce a strategy document aimed at those responsible for planning and commissioning novel patient services outside of traditional care settings.

Point of Care Testing: National Strategic Guidance for at Point of Need Testing outlines the strategic requirements necessary to adopt POCT where it is needed and how to deliver safe and high quality POCT within an accreditable framework.

Increasingly, diagnostics are being flagged as the enabler of innovative, effective, patient-centred care closer to the patient’s home, at the point of need. By setting out the questions that need to be considered, and who the experts are that understand the clinical need, the IBMS says it is, “placing a marker down and stating that diagnostic testing is the expert domain of our members, whatever the setting.”

The IBMS is also offering those responsible for commissioning and developing diagnostic services in new care settings the information, and the access to laboratory experts, they need to ensure safe and clinically effective POCT.

The paper outlines:

  • laboratory experts should be used as a source of trusted advice to support the design, assessment, implementation, and delivery of diagnostic services outside of the traditional laboratory setting

  • engagement across healthcare organisations is critical to understand the flow of diagnostic information, from wherever it is undertaken, to the patient record, with visibility for all clinical staff who have reason to access this information

  • full and properly costed financial resources need to be identified to support high quality, fit for purpose and safe POCT services

  • new technology brings new opportunities for the better use of the existing workforce, creating a more agile workforce. 

The IBMS encourages the sharing of this document with service leaders embarking on testing outside of the traditional laboratory setting – to inform and advise the development of innovative, safe and effective patient pathways.

The paper will be shared widely across government channels and to all relevant organisations.

Read the full document here - Point of Care Testing: National Strategic Guidance for at Point of Need Testing.

FEATURES

The importance of an integrated diagnostic pathway within sepsis care

Current challenges within sepsis diagnostics and AMR show the need for a standardised blood culture pathway. Stefan Schraag explores how the med tech industry can support this through greater education and innovation. This article follows on from a stakeholder event taking a holistic view of the blood culture pathway and encouraging diagnostic integration beyond the walls of laboratories.

Endogenous retroviruses: research published in the recent scientific literature

Relics of ancient viruses, endogenous retroviruses that can be found in human DNA, have recently found exposure in the media. But what range of applications can be found in the recent literature? Here, Pathology in Practice Science Editor Brian Nation compiles a small selection of current research interest in the field.

On the cusp of change – the future of clinical viscosity testing

In the second of two articles for Pathology in Practice, retired biomedical scientist David Norcliffe, with David Manuel, looks at how clinical viscosity testing can be used more widely, with the measurement of viscosity having a considerable number of possible applications which are receiving further investigation.

Delivering science and celebrating achievement at IBMS Congress 2023

The biennial IBMS Congress will return to the International Convention Centre in Birmingham in September, the focus once again being on the very best that biomedical science and commercial colleagues have to offer. Here, Pathology in Practice provides a further brief preview of the four-day event.

PRODUCTS

LATEST ISSUEs

May 2023
January 2023
September 2020

Upcoming Events

UKMedLab23

Royal Armouries, Leeds
12-14 June 2023

Liverpool Pathology 2023

University of Liverpool
27-29 June

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

Annual SHOT Symposium 2023

Etihad Stadium, Manchester, M11 3FF
4 July 2023

IBMS Congress 2023 - Linking learning to the laboratory

ICC Birmingham
25-28 September 2023

MEEGID XVI

Hilton Dresden, Germany
14-17 November 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

UKMedLab23

Royal Armouries, Leeds
12-14 June 2023

Liverpool Pathology 2023

University of Liverpool
27-29 June

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

Annual SHOT Symposium 2023

Etihad Stadium, Manchester, M11 3FF
4 July 2023

IBMS Congress 2023 - Linking learning to the laboratory

ICC Birmingham
25-28 September 2023

MEEGID XVI

Hilton Dresden, Germany
14-17 November 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2023 Step Communications Ltd. Registered in England. Registration Number 3893025